Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study

समान संसाधन

• No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a ‘thorough QT/QTc study’ performed according to ICH guidelines
  द्वारा: Donado, Ester, और अन्य
  प्रकाशित: (2010)
• Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial
  द्वारा: Marmouz, Farid, और अन्य
  प्रकाशित: (2011)
• A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
  द्वारा: Lukat, KF, और अन्य
  प्रकाशित: (2013)
• Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure
  द्वारा: Ballester, Maria Rosa, और अन्य
  प्रकाशित: (2015)
• Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial
  द्वारा: Täubel, Jörg, और अन्य
  प्रकाशित: (2016)